A RETROSPECTIVE STUDY ON THE INCIDENCE OF NEONATAL JAUNDICE IN SCBU UNIVERSITY OF BENIN TEACHING HOSPITAL

Abstract

The study focused on "Assessing the Incidence, Risk Factors, Management, and Treatment of Neonatal Jaundice in the Special Care Baby Unit (SCBU) at the University of Benin Teaching Hospital (UBTH)." A quantitative survey research design was adopted to investigate various aspects of neonatal jaundice, including its incidence, associated risk factors, effectiveness of management strategies, and treatment outcomes. A structured questionnaire was developed to collect data from a sample of 120 respondents, including healthcare professionals and parents. Data collection involved the use of frequency tables, simple percentages, mean, and standard deviation to analyze the responses. Additionally, a t-test was employed to test the hypotheses regarding the incidence of neonatal jaundice, the influence of demographic and clinical factors, and the effectiveness of management strategies. The findings revealed that there was a significant incidence of neonatal jaundice in the SCBU at UBTH over the past five years, with an increasing trend observed. The results indicated that specific demographic and clinical factors, such as birth weight and gestational age, significantly influenced the incidence of neonatal jaundice. The management strategies employed, including phototherapy and exchange transfusion, were generally perceived as effective in treating the condition. However, the study also identified areas where the current protocols did not meet the expected standards, particularly in terms of treatment success rates. In conclusion, the study highlighted the critical need for enhanced management protocols and continued research to improve treatment outcomes for neonatal jaundice. It emphasized the importance of addressing demographic and clinical factors in the management of the condition and suggested the need for ongoing evaluation of the effectiveness of current strategies. The recommendations included improving healthcare infrastructure, standardizing treatment protocols, and investing in staff training to ensure better management of neonatal jaundice. Future research should focus on longitudinal studies to track long-term outcomes and evaluate the impact of new interventions on neonatal jaundice management.

CHAPTER ONE

INTRODUCTION

1.1 Background to the Study

Neonatal jaundice is a prevalent condition that affects newborns, characterized by high levels of bilirubin in the blood, resulting in a yellowish discoloration of the skin and eyes. This condition is of significant concern in neonatology due to its potential to cause severe neurological damage if left untreated. The Special Care Baby Unit (SCBU) at the University of Benin Teaching Hospital (UBTH) has been at the forefront of managing and studying this condition. Studies have shown that neonatal jaundice, if not properly managed, can lead to complications such as kernicterus, a form of brain damage caused by excessive bilirubin levels (Burke et al., 2020).

Neonatal jaundice can be physiological or pathological. Physiological jaundice typically appears after the first 24 hours of life, peaking between the second and fourth days and usually resolving by the end of the first week. Pathological jaundice, however, can present within the first 24 hours and is often indicative of underlying health issues such as hemolytic disease, infections, or metabolic disorders. The effective management of neonatal jaundice involves timely diagnosis, monitoring of bilirubin levels, and appropriate therapeutic interventions such as phototherapy or exchange transfusion (Amar & Sinduja, 2018).

In developing countries like Nigeria, neonatal jaundice poses a significant public health challenge due to limited access to healthcare facilities, inadequate health education, and insufficient resources for effective management. The University of Benin Teaching Hospital, as a tertiary healthcare institution, plays a crucial role in addressing this challenge by providing specialized care and conducting research to improve outcomes for affected neonates. Recent data highlight the need for better healthcare infrastructure to manage neonatal jaundice effectively (Beachy, 2020).

This retrospective study aims to analyze the incidence of neonatal jaundice in the SCBU at UBTH, exploring trends, outcomes, and factors influencing its prevalence and management over recent years. By understanding these factors, healthcare providers can develop more effective strategies to prevent and treat neonatal jaundice, thereby reducing its incidence and associated complications (Kassa et al., 2018).

Phototherapy is one of the most common treatments for neonatal jaundice. It involves exposing the baby to a type of fluorescent light that helps break down bilirubin in the skin. This treatment is generally safe and effective, though it requires careful monitoring to avoid potential side effects such as dehydration and skin rashes. Studies have shown that early and consistent use of phototherapy can significantly reduce bilirubin levels and prevent severe outcomes (Bahbah et al., 2023).

Exchange transfusion is another critical treatment for severe cases of neonatal jaundice, especially when bilirubin levels are dangerously high. This procedure involves removing small amounts of the baby's blood and replacing it with donor blood to rapidly reduce bilirubin levels. While effective, exchange transfusion is a more invasive procedure and carries risks such as blood transfusion reactions and infections. Therefore, it is typically reserved for cases where phototherapy alone is insufficient (Arianna, 2017).

Several factors can influence the incidence and severity of neonatal jaundice, including genetic predispositions, maternal health, and neonatal factors such as prematurity and birth trauma. Research has shown that certain populations, including those with a higher prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency, are at increased risk for developing severe jaundice. Understanding these risk factors is crucial for early identification and management (Ekwochi et al., 2022).

The role of maternal health in neonatal jaundice is also significant. Conditions such as diabetes, Rh incompatibility, and certain infections during pregnancy can increase the risk of jaundice in newborns. Maternal education on these risk factors and the importance of early neonatal care can help reduce the incidence and severity of jaundice. Public health initiatives aimed at improving maternal and neonatal healthcare services are essential in this regard (Tavakolizadeh et al., 2018).

Studies have also highlighted the importance of timely and accurate diagnosis in the management of neonatal jaundice. Early screening and monitoring of bilirubin levels in newborns can help identify those at risk and ensure prompt treatment. Hospitals and healthcare facilities need to be equipped with the necessary tools and trained personnel to perform these screenings effectively. This is particularly important in resource-limited settings where delays in diagnosis and treatment can lead to adverse outcomes (Scrafford et al., 2023).

1.2 Statement of Problem

Despite significant advances in the understanding and management of neonatal jaundice, several gaps in knowledge and practice remain that need to be addressed. One critical gap is the inconsistency in the availability and utilization of screening and diagnostic tools for early detection of neonatal jaundice, especially in resource-limited settings. Many healthcare facilities lack the necessary equipment and trained personnel to perform timely bilirubin level assessments, leading to delays in diagnosis and treatment (Ekwochi et al., 2022).

Additionally, while phototherapy is widely recognized as an effective treatment for neonatal jaundice, there is a lack of standardized protocols for its use in different healthcare settings. Variations in the implementation of phototherapy, including the intensity and duration of light exposure, can impact its efficacy and safety. Research is needed to establish uniform guidelines that can be adapted to various contexts, ensuring that all infants receive optimal care (Amar & Sinduja, 2018).

Another significant gap is the limited understanding of the long-term outcomes of infants who undergo treatments for neonatal jaundice. While immediate complications such as kernicterus are well-documented, there is insufficient data on the long-term neurodevelopmental impacts of high bilirubin levels and their treatment. Longitudinal studies are necessary to track the development of these children and identify any potential late-onset effects (Burke et al., 2020).

Furthermore, the influence of genetic and environmental factors on the incidence and severity of neonatal jaundice is not fully understood. For instance, populations with higher prevalence rates of G6PD deficiency or other genetic conditions may have different responses to standard treatments. More research is needed to tailor interventions to these specific needs and improve outcomes for all demographic groups (Scrafford et al., 2023).

Lastly, there is a need for enhanced public health education and awareness programs to inform parents and caregivers about the signs, risks, and management of neonatal jaundice. Many cases of severe jaundice result from delayed recognition and treatment, highlighting the importance of education in early intervention (Kassa et al., 2018). Addressing these gaps through targeted research and policy initiatives can significantly improve the management and outcomes of neonatal jaundice.

1.3 Objectives of the Study

The primary objective of this study is to conduct a retrospective analysis of the incidence of neonatal jaundice in the SCBU at the University of Benin Teaching Hospital. The specific objectives are:

1. To determine the incidence rate of neonatal jaundice in the SCBU at UBTH over the past five years.
2. To identify and analyze the demographic and clinical factors associated with neonatal jaundice in this population.
3. To evaluate the outcomes and effectiveness of various management strategies employed in treating neonatal jaundice in the SCBU.

1.4 Research Questions

To guide the study, the following research questions were formulated:

1. What is the incidence rate of neonatal jaundice in the SCBU at the University of Benin Teaching Hospital over the past five years?
2. What demographic and clinical factors are associated with the incidence of neonatal jaundice in this population?
3. How effective are the management strategies employed in the SCBU at UBTH in treating neonatal jaundice?

1.5 Research Hypotheses

The study will test the following hypotheses:

1. There is no significant incidence of neonatal jaundice in the SCBU at the University of Benin Teaching Hospital.
2. Specific demographic and clinical factors do not significantly influence the incidence of neonatal jaundice in this population.
3. The management strategies employed in the SCBU at UBTH are not effective in treating neonatal jaundice.

1.6 Significance of the Study

The significance of this study on the incidence of neonatal jaundice in the Special Care Baby Unit (SCBU) at the University of Benin Teaching Hospital (UBTH) is multifaceted, encompassing clinical, public health, and educational perspectives. Neonatal jaundice is a common condition affecting newborns worldwide, and understanding its incidence, risk factors, and outcomes is crucial for improving neonatal care and reducing associated morbidity and mortality.

From a clinical standpoint, this study provides essential data on the patterns and prevalence of neonatal jaundice within a specific healthcare setting. By analyzing retrospective data, the study can identify trends and potential risk factors associated with jaundice in neonates. This information is vital for clinicians to develop targeted interventions and improve diagnostic and treatment protocols. For instance, understanding the timing of jaundice onset and its correlation with various maternal and neonatal factors can help healthcare providers implement more effective screening and management strategies.

Furthermore, the study's findings can contribute to the development of standardized treatment protocols and guidelines for managing neonatal jaundice. Currently, there are variations in the treatment approaches for jaundice, particularly in resource-limited settings. By providing evidence-based insights, this study can help harmonize treatment practices, ensuring that all affected newborns receive timely and appropriate care. This could potentially reduce the incidence of severe jaundice and its complications, such as kernicterus, thereby improving neonatal health outcomes.

In the context of public health, this study has significant implications for healthcare planning and resource allocation. Neonatal jaundice, if not properly managed, can lead to severe health issues and increased healthcare costs due to prolonged hospital stays and the need for intensive treatments. By highlighting the prevalence and risk factors of jaundice, this study can inform public health authorities about the magnitude of the problem and the need for adequate resources and infrastructure to manage it effectively. This is particularly important in developing countries like Nigeria, where healthcare resources are often limited.

Moreover, the study can serve as a basis for public health campaigns aimed at raising awareness about neonatal jaundice among parents and caregivers. Educating the public about the signs and symptoms of jaundice, the importance of early detection, and the available treatment options can lead to earlier interventions and better outcomes for affected infants. Increased awareness can also reduce the stigma associated with jaundice and encourage families to seek timely medical help.

The educational significance of this study cannot be overstated. It provides valuable data for medical and nursing students, as well as healthcare professionals, enhancing their understanding of neonatal jaundice and its management. The findings can be incorporated into the curriculum for training healthcare providers, ensuring that future generations of clinicians are well-equipped to handle this common neonatal condition. Additionally, the study can stimulate further research in the field, encouraging academic and clinical inquiries into more effective ways to prevent and treat neonatal jaundice.

1.7 Scope of the Study

This study was confined to the Special Care Baby Unit (SCBU) at the University of Benin Teaching Hospital. It focused on neonates diagnosed with jaundice within the first 28 days of life over a five-year period from January 2018 to December 2022. The study analyzed medical records to determine the incidence rate, demographic and clinical factors, and management outcomes of neonatal jaundice. Only cases managed within the SCBU were included, excluding those referred to or from other facilities.

1.8 Operational Definition of Terms

1. Neonatal Jaundice: A medical condition in newborns characterized by high levels of bilirubin in the blood, causing a yellow discoloration of the skin and eyes.
2. Bilirubin: A yellow compound that occurs in the normal catabolic pathway that breaks down heme in red blood cells.
3. Phototherapy: A treatment for neonatal jaundice that involves exposing the baby to a type of fluorescent light that helps break down bilirubin in the skin.
4. Exchange Transfusion: A medical procedure used to treat severe neonatal jaundice by removing the newborn's blood and replacing it with donor blood.
5. Special Care Baby Unit (SCBU): A hospital unit specialized in the care of premature or ill newborns requiring intensive medical attention.
6. Kernicterus: A rare but serious form of brain damage that can occur in newborns with severe jaundice if not treated promptly.
7. Gestational Age: The age of a fetus or newborn, usually expressed in weeks, from the first day of the mother's last menstrual period.
8. Incidence Rate: The rate at which new cases of a condition, such as neonatal jaundice, occur in a specific population during a defined period.

59 PAGES